en

PRODUCT DETAIL

AFONILUM SR 250

Code 9521C
MA number 14/0351/18-S
Product Form: cps plg 50x250 mg (blis.PP/Al)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: National
Therapeutic Class: 14 - BRONCHODILATANTIA, ANTIASTHMATICA
ATC:
R RESPIRATORY SYSTEM
R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03D OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03DA Xanthines
R03DA04 Theophylline
Shelf life: 60
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10a well-established use application
MA issued: 09.08.1994
Pediatric indication: Yes
Pediatric posology: Yes
Pediatric contraindication: Yes
Pediatric warnings: Yes
PIL: PIL_AFONILUM SR_125 mg, 250 mg_07_2022.pdf  
SPC: SPC_AFONILUM SR_125 mg, 250 mg_07_2022.pdf  
Safety feature Yes
Data update: 22.10.2018
eu-flag.png sk-flag.png